INTRODUCTION
Current antibiotic resistance concerns make it necessary for swine production systems to devise alternative methods to modulate intestinal microbial populations to control pathogen-associated suppression of growth and production (Gaskins et al., 2002; McDermott et al., 2002; Barton et al., 2003; Gilchrist et al., 2007) . The utilization of probiotics in swine production may be a viable alternative as indicated by contemporary research (Collington et al., 1990; De Angelis et al., 2006; Collado et al., 2007) . Recent evidence suggests that the live yeast Saccharomyces cerevisiae boulardii may be one such probiotic capable of eliciting changes to the intestinal microbiota (Plein and Hotz, 1993; Izadnia et al., 1998; Keyser et al., 2007) concurrent with host-specific alterations (Plein and Hotz, 1993; Kamm et al., 2004; Schroeder et al., 2004) resulting in improved performance. However, similar to most other probiotics, the mechanism(s) whereby S. boulardii results in beneficial physiological effects is poorly defined. Here, we are the first to detail the effects of S. boulardii on immune and cortisol responses to endotoxin challenge in young pigs. Moreover, these data are among the first to partially elucidate aspects of a potentially beneficial immune/neuroendocrine interaction profile before challenge that facilitates pig survival after challenge.
MATERIALS AND METHODS
All experimental procedures were in accordance with the Guide for the Care and Use of Agricultural Animals in Research and Teaching (FASS, 2010) and approved by the Institutional Animal Care and Use Committee of the USDA-ARS.
Animals, Experimental Design, and Immune Challenge
Thirty terminal cross PIC Line 201 barrows (21 to 28 d of age) from 10 different litters were obtained from Murphy Brown LLC (Dalhart, TX). The pigs were transferred to the USDA Livestock Issues Research Unit nursery building where they were weighed, assigned to individual pens (1.22 × 0.61 m), and allowed ad libitum access to feed supplemented with (n = 15) and without (n = 15) the inclusion of Saccharomyces cerevisiae boulardii (Scb; Lallemand Animal Nutrition, Milwaukee, WI; 182 g/t) and water. Litters were divided equally between both treatments. Pigs were subsequently weighed on d 7 and 14 to calculate ADG. The piglets were given 2 wk to adjust to their surroundings and diet. One day before lipopolysaccharide (LPS) infusion, all 30 pigs were nonsurgically fitted with an indwelling jugular catheter as described previously (Carroll et al., 1999) . Piglets were then given 24 h to recover from the cannulation procedure before collection of blood samples commenced. Before collection of the initial sample, an extension was attached to the catheter to allow for remote sample collection without handling the animals. Blood samples were taken at 30-min intervals from 1 h before LPS infusion to establish baseline values within each animal as previously validated (Carroll et al., 2005; Reuter et al., 2008) . Lipopolysacharide (Escherichia coli 0111:B4; Sigma L-2630, Sigma Chemical, St. Louis, MO; 25 µg/kg of BW) administration was given manually through the catheter using a 3-mL syringe. Blood samples were then taken at 30-min intervals for 6 h post LPS infusion. Approximately 5 mL of blood was collected at each time point into a serum tube and allowed to clot for 1 h at room temperature. Tubes were then centrifuged (1,400 × g for 20 min at 20°C). Serum was collected and aliquoted into microcentifuge tubes and stored at −80°C for later analysis. Total white blood cell and white blood cell differential counts were performed on whole blood samples taken hourly from 0 to 6 h and 24 h using a Cell-Dyn (Abbott Laboratories, Abbott Park, IL) within 1 h of collection.
Serum Analysis
Serum concentration of cortisol (ng/mL) was determined by RIA (Coat-a-Count Assay, Diagnostic Products Corp., Los Angeles, CA) as previously performed and validated (Frank et al., 2003) . Concentration of serum cytokines IL-1β, IL-6, tumor necrosis factor-α (TNF-α), and interferon-γ (IFN-γ) was determined according to the manufacturer's protocol using a porcine-specific ELISA kit for proinflammatory cytokines (SearchLight Porcine Inflammatory Cytokine Array #84664, Pierce, Rockford, IL). All assays were performed in duplicate. The intra-and interassay CV were 9 and 12%, respectively, for cytokine analyses and 9 and 11%, respectively, for cortisol.
Neutrophil Phagocytic and Oxidative Burst
Six milliliters of peripheral blood was collected into lithium heparinized (Thermo Fisher Scientific, Pittsburgh, PA) evacuated tubes from each animal immediately before the LPS challenge. The phagocytic stimulus was an E. coli isolated from the spleen of a septicemic calf. The E. coli was heat-killed (60°C for 30 min) and fluorescently labeled with propidium iodide (10 9 cfu/mL in 50 µg/mL of propidium iodide) under gentle agitation for 2 h. Escherichia coli were washed and stored at −80°C at a concentration of 10 9 cfu/ mL. Two hundred microliters of whole blood was added to the bottom of a 1.7-mL microcentrifuge tube and placed in an ice bath for 15 min. Forty microliters of working concentration of dihydrorhodamine (100 uM) and 40 µL of E. coli were added to the whole blood, which was vortexed and incubated at 38.5°C for 5 or 30 min. After incubation, the samples were immediately submerged in an ice bath, and 40 uL of 0.4% trypan blue was added to each tube. Erythrocytes were hypotonically lysed and leukocytes resuspended in 1× PBS. Data were analyzed by 2-color flow cytometry on a Cell Lab Quanta SC (Beckman Coulter, Fullerton, CA).
Statistical Analyses
Five piglets (4 controls and 1 Scb-treated) died as a result of LPS infusion, and data obtained from these animals were excluded from the analyses. All data from surviving animals (n = 25) were subjected to ANOVA specific for repeated measures using the Mixed procedure (SAS Inst. Inc., Cary, NC). Sources of variation included litter, time, and their interactions. Specific treatment comparisons were made using Fisher's protected least significant difference with comparisons of P < 0.05 considered significant. Pearson correlation Yeast effects on immune responses in pigs coefficients were determined among the amplitude of responses (peak concentrations).
RESULTS

Growth and Mortality
Piglets supplemented with Scb had greater (P < 0.05) ADG than control pigs (0.148 ± 0.019 vs. 0.089 ± 0.015 kg/d, respectively) throughout the entire study. After LPS infusion, 2 control pigs died within the first 2 h with an additional 1 pig dying by h 3 and 4 each (n = 4 total pig deaths) as a result of LPS inoculation. One Scb-treated piglet died as a result of LPS dosing by 3 h after dosing (n = 1 total pig death).
Differential Cell Populations
Total white blood cell populations were greater (P < 0.05) in Scb-treated pigs than control animals before LPS administration (20.8 × 10 3 ± 1.37 vs. 16.7 × 10 3 ± 0.84 cells/µL, respectively) before being equally suppressed (P > 0.05) after LPS and returning to baseline by 24 h (Figure 1 ). Similar LPS response patterns were also observed for lymphocyte and neutrophil counts (data not shown). However, lymphocyte counts were greater (P < 0.05) in control animals when compared with treated at the 5 and 6 h time points (2.7 × 10 3 ± 0.48 vs. 1.20 × 10 3 ± 0.22 cells/µL, respectively). Treatment-associated differences in basophil, eosinophil, and monocyte counts were not observed (P > 0.05; data not shown).
Neutrophil Phagocytic and Oxidative Burst
The ability of neutrophils to phagocytize an enteropathogenic E. coli was not influenced (P > 0.05) by Scb treatment (Figure 2a ). However, there was a treatment × incubation time interaction (P < 0.04) with respect to the percentage of neutrophils undergoing an oxidative burst, whereas at the 5-min incubation Scb-treated pigs had a reduced number of neutrophils producing an oxidative burst but at the 30-min incubation were no longer different from the control pigs (P > 0.05; Figure 2b ). There was no influence of treatment (P > 0.05) on the mean fluorescence intensity of either the phagocytosis or oxidative burst of the neutrophils (data not shown). 
Circulating Cortisol Concentrations
Before LPS administration, cortisol concentrations were less (P < 0.05) in Scb-treated piglets when compared with controls (Figure 3 ; 129.6 ± 27.28 vs. 217.2 ± 31.70 ng/mL, respectively). Cortisol concentrations were increased (P < 0.05) from baseline in Scb-treated and control pigs, but control animals had greater (P < 0.05) cortisol production at 0.5 and 1 h post LPS administration than Scb-treated animals (590.7 ± 74.6 vs. 414.0 ± 58.1 ng/mL, respectively). Peak concentrations were then similar (P > 0.05) between treatments from 1.5 to 24 h when both treatments returned to baseline.
Circulating Cytokine Concentration
Before LPS administration, baseline concentrations of IL-1β did not differ (P > 0.05) between treatments (Figure 4 ). Starting at 1.5 h post LPS, IL-1β concentrations were greater (P < 0.05) in control animals and peaked at 2 h (143.3 ± 68.4 vs. 31.3 ± 19.6 pg/mL, respectively). Interleukin-1β continued to be greater (P < 0.05) in control animals until the 4-h post LPS time point. The IL-1β concentration in Scb-treated pigs did not differ (P > 0.05) from baseline for the duration of the time period analyzed. Although IL-6 concentrations in both groups increased (P < 0.05) from baseline after being dosed with LPS, IL-6 concentrations were greater (P < 0.05) in controls when compared with Scb-treated animals by 1.5 h after LPS. Peak IL-6 concentrations occurred at the 2-h time point (136.6 ± 24.2 vs. 78.9 ± 12.3 pg/mL, respectively) and continued to be greater before both groups returned to baseline at 4 h post LPS ( Figure 5 ). Circulating concentrations of TNF-α were similarly increased (P < 0.05) from baseline in both treatments after the LPS challenge at the 0.5-and 1-h time points (Figure 6 ). However, circulating TNF-α concentrations peaked at 1.5 h and were greater (P < 0.05) than the concentrations observed in controls at the same time point (837.6 ± 76.2 vs. 376.3 ± 93.0 pg/ mL, respectively) and the subsequent peak of TNF-α in controls occurring at 2 h. Concentrations of TNF-α then returned to baseline by 2.5 h and did not differ (P > 0.05) between treatments. The circulating concentrations of IFN-γ did not differ (P > 0.05) between treatments before LPS administration until 2 h post administration (Figure 7) . However, Scb-treated animals produced more (P < 0.05) IFN-γ than controls from 2.5 to 5.5 h post LPS with peak production occurring at 3 h (159.182 ± 51.8 vs. 55.6 ± 20.1 pg/mL, respectively). Both treatments returned to baseline by 6 h and did not differ (P > 0.05).
DISCUSSION
Currently, little is known about the mechanisms by which Scb, as well as many other probiotics, result in improved production, animal health, and increased growth. Here, S. cerevisiae subtype boulardii was found to increase ADG and reduced LPS-induced mortality when compared with controls. This phenomenon is similar to the use of subtherapeutic antibiotics described elsewhere (Gaskins et al., 2002) . Concomitant with these attributes, the inclusion of S. boulardii resulted in a unique immune/cortisol profile distinct from control animals.
Although this is the first report of the potential ability of Scb to prevent LPS-induced mortality (to our knowledge), the growth-related benefits of Scb have been reported elsewhere in other species (Gil de los Values represent the mean ± SEM for barrows assigned to 1 of 2 treatment groups: with (Scb; n = 15) and without (control; n = 15) the in-feed inclusion of Scb for 16 d. The LPS induced a time-dependent increase (P < 0.01) in serum cortisol. The cortisol concentration was greatest (P < 0.05) in controls until 1 h, greatest in Scb at 1.5 h (P < 0.05), and then did not differ. Values represent the mean ± SEM for barrows assigned to 1 of 2 treatment groups: with (Scb; n = 15) and without (control; n = 15) the in-feed inclusion of Scb for 16 d. The LPS induced a time-dependent increase (P < 0.01) in serum IL-1β that tended to be delayed and suppressed by Scb (P < 0.06). Santos et al., 2005; Keyser et al., 2007) . Improved growth and reduced mortality may result in part from potentially beneficial probiotic properties of S. boulardii that have been reviewed elsewhere (Carson and Riley, 2003; Broussard and Surawicz, 2004) . Specifically, S. boulardii has been found to facilitate the production of trophic factors to increase gut-associated lymphoid tissue-derived IgA production, improve mucosal barrier function, and improve brush border membrane integrity, resulting in improved host immune defenses, digestion, and absorption of nutrients Buts, 2009a,b) . Other research indicates that S. boulardii may also directly or indirectly suppress populations of potentially pathogenic or growth-suppressing microorganisms (Pochapin, 2000; Akil et al., 2006; Cindoruk et al., 2007; Czerucka et al., 2007; de Vrese and Schrezenmeir, 2008) .
The elucidation of specific mechanisms by which Scb improved growth and reduced mortality associated with the LPS challenge model is beyond the scope of this report. However, these results combined with previous studies (Butts and Sternberg, 2008; Taub, 2008; Savino et al., 2009 ) highlight its potential to modulate immune and neuroendocrine interactions. Specifically, white blood cell, lymphocyte, and neutrophil cell populations were increased in Scb-treated animals before LPS administration. After LPS challenge, immune cell populations immediately decreased regardless of treatment before returning to baseline by 24 h as previously observed (Williams et al., 2009) . In contrast to the greater neutrophil count, the percentage of neutrophils producing an oxidative burst in response to the E. coli was delayed in Scb-treated animals. These data contrast with those from rats and mice, whereas many probiotics increase phagocytic and oxidative burst capacities of neutrophils (Calder and Kew, 2002) . Due to the greater number of neutrophils in peripheral circulation and presumably greater potential to be recruited into infected tissues, if data were expressed as the total number of neutrophils either phagocytizing or producing an oxidative burst, Scb-treated pigs had greater responses (data not shown). Furthermore, the increased neutrophil population may also be important because neutrophils are known to be an important effecter of inflammatory responses including the expression of a variety of cytokines including IL-1β (Scapini et al., 2000) .
The concentrations of IL-1β and IL-6 in response to LPS administration were suppressed in Scb-treated animals relative to controls. However, the addition of S. bouldardii accelerated and increased peak concentrations of circulating TNF-α while also sustaining greater IFN-γ concentrations relative to controls. In control animals, the TNF-α and IL-1β responses to LPS found in this study are similar to previous reports of LPS responses in pigs (Carroll et al., , 2005 Williams et al., 2009) . Similarly, the IL-6, IFN-γ, and cortisol responses to LPS in this study are similar to those reported elsewhere (Webel et al., 1998; Wright et al., 2000; Frank et al., 2003) . This report also elucidates the suppression of circulating concentrations of IL-1β and IL-6, an initial spike of TNF-α secretion, and increased IFN-γ concentrations in Scb-treated animals when compared with controls. The effects of probiotics on cytokine production warrants further study because current literature is contradictory (Dharmani and Chadee, 2008; de Roock et al., 2010; Vissers et al., 2010) . The resultant inflammatory immune response to LPS may be at least partially mediated by TNF-α production Values represent the mean ± SEM for barrows assigned to 1 of 2 treatment groups: with (Scb; n = 15) and without (control; n = 15) the in-feed inclusion of Scb for 16 d. The LPS induced a time-dependent increase (P < 0.01) in serum IL-6 that tended to be suppressed by Scb (P < 0.06) when compared with control. Production of IL-6 did not differ between groups at 2.5 h. Figure 6 . Effect of Saccharomyces cerevisiae boulardii (Scb) supplementation (182 g/t of feed) on the serum tumor necrosis factor-α (TNF-α) response of pigs to an intravenous challenge with 25 µg/kg of lipopolysaccharide (LPS). Values represent the mean ± SEM for barrows assigned to 1 of 2 treatment groups: with (Scb; n = 15) and without (control; n = 15) the in-feed inclusion of Scb for 16 d. The LPS induced a time-dependent increase (P < 0.01) in serum TNF-α that was accelerated and increased (P < 0.06) by Scb at 1.5 h when compared with peak production in control. Differences in TNF-α production were not observed after 2 h. and then followed by a prolonged IFN-γ regulation of the inflammatory response. Cumulatively, Scb supplementation resulted in differential cytokine production profiles from a larger pool of immune cells while in the presence of reduced cortisol concentrations before and during the initial response to LPS challenge. The prechallenge and initial suppression of cortisol production after LPS administration in Scb-treated animals may be particularly important because it is a primary inhibitor of immune function (Westly and Kelley, 1984; Borghetti et al., 2006) . The cumulative Scb-induced immune-neuroendocrine LPS response described here may presumably function to facilitate short-term clearance of the pathogen. However, regulation of the immune response may be prolonged and heightened at a cellular level via cytokine production independent of cortisol, thus precluding neuroendocrine suppression of the initial immune response and other growth-related functions (Wise et al., 1991; Weiler et al., 2003; Borghetti et al., 2006) . Furthermore, supplementation of Scb to enhance growth in weaned pigs may also occur via suppressing acute responses to pathogenic challenges and thus potentially preventing the diversion of energy away from maintaining innate and adaptive immune responses and liberating it for growth-related processes.
Future studies should evaluate the role of potentially beneficial probiotics on cell cycle and cell population density combined with suppressed cortisol concentrations before challenge, and the subsequent cytokine profiles, as a means to potentially prevent pathogeninduced inflammatory responses. These results also highlight the necessity to analyze multiple immune and neuroendocrine variables to effectively describe the immune responses to pathogenic challenge and resultant impact on growth. Figure 7 . Effect of Saccharomyces cerevisiae boulardii (Scb) supplementation (182 g/t of feed) on the serum interferon-γ (IFN-γ) response of pigs to an intravenous challenge with 25 µg/kg of lipopolysaccharide (LPS). Values represent the mean ± SEM for barrows assigned to 1 of 2 treatment groups: with (Scb; n = 15) and without (control; n = 15) the in-feed inclusion of Scb for 16 d. The LPS induced a timedependent increase (P < 0.01) in serum IFN-γ that was increased by Scb (P < 0.06) when compared with control.
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